Predicted protein targets (top 9)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | AXL | P30530 | 9/20 | 0.41 |
| ▸ | MAP2K3 | P46734 | 2/20 | 0.39 |
| ▸ | ROCK2 | O75116 | 1/20 | 0.39 |
| ▸ | BTK | Q06187 | 1/20 | 0.39 |
| ▸ | P2RX7 | Q99572 | 2/20 | 0.38 |
| ▸ | MAP4K4 | O95819 | 3/20 | 0.38 |
| ▸ | PRKCQ | Q04759 | 1/20 | 0.37 |
| ▸ | HRH4 | Q9H3N8 | 1/20 | 0.36 |
| ▸ | HRH3 | Q9Y5N1 | 1/20 | 0.36 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL22013143 | 0.81 | MAPT (0.42) | ROCK2 | |
| SCHEMBL14938741 | 0.77 | MAP4K4 (0.40) | MAP4K4HRH4HRH3 | |
| SCHEMBL31390848 | 0.73 | HRH3 (0.56) | HRH3 | |
| SCHEMBL20119411 | 0.72 | SMPD3 (0.43) | ROCK2PRKCQ | |
| SCHEMBL17119925 | 0.69 | P2RX7 (0.44) | P2RX7 | |
| SCHEMBL31378785 | 0.69 | MAP2K3 (0.51) | AXLMAP2K3 | |
| SCHEMBL17626721 | 0.69 | HRH3 (0.71) | BTKHRH4HRH3 | |
| SCHEMBL18691294 | 0.69 | HRH3 (0.71) | BTKHRH4HRH3 | |
| SCHEMBL18691295 | 0.69 | HRH3 (0.71) | BTKHRH4HRH3 | |
| SCHEMBL22013122 | 0.69 | MAP4K4 (0.53) | MAP4K4HRH3 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-3882247-A1 | SIX-MEMBERED AND SIX-MEMBERED HETEROCYCLIC COMPOUND AND USES THEREOF SERVING AS PROTEIN RECEPTOR KINASE INHIBITOR | Shanghai Ennovabio Pharmaceuticals Co., Ltd. (CN) | 2021-09-22 | — | — | EP | disclosed |